Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply to A.S. Garden.
Ferris RL, Burtness B, Flamand Y. Ferris RL, et al. Among authors: flamand y. J Clin Oncol. 2022 Apr 1;40(10):1133-1134. doi: 10.1200/JCO.22.00063. Epub 2022 Feb 16. J Clin Oncol. 2022. PMID: 35171688 No abstract available.
PediCARE: Development of a poverty-targeted intervention for pediatric cancer.
Umaretiya PJ, Revette A, Seo A, Flamand Y, Ilcisin L, Zheng DJ, Bhatia S, Wolfe J, Bona K. Umaretiya PJ, et al. Among authors: flamand y. Pediatr Blood Cancer. 2021 Oct;68(10):e29195. doi: 10.1002/pbc.29195. Epub 2021 Jun 30. Pediatr Blood Cancer. 2021. PMID: 34190405 Free PMC article.
Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001.
Athale UH, Flamand Y, Blonquist T, Stevenson KE, Spira M, Asselin BL, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Welch JJG, Harris MH, Neuberg DS, Sallan SE, Silverman LB. Athale UH, et al. Among authors: flamand y. Pediatr Blood Cancer. 2022 Aug;69(8):e29581. doi: 10.1002/pbc.29581. Epub 2022 Mar 22. Pediatr Blood Cancer. 2022. PMID: 35316569
Impairment of health-related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL Consortium.
Welch JJG, Flamand Y, Stevenson KE, Neuberg DS, Athale UH, Kelly KM, Laverdiere C, Michon B, Place AE, Sallan SE, Silverman LB, Vrooman LM. Welch JJG, et al. Among authors: flamand y. Pediatr Blood Cancer. 2023 Nov;70(11):e30560. doi: 10.1002/pbc.30560. Epub 2023 Jul 17. Pediatr Blood Cancer. 2023. PMID: 37461125 Clinical Trial.
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols.
Valtis YK, Flamand Y, Shimony S, Place AE, Silverman LB, Vrooman LM, Brunner AM, Sallan SE, Wadleigh M, Stone RM, DeAngelo DJ, Luskin MR. Valtis YK, et al. Among authors: flamand y. Leukemia. 2024 Mar;38(3):482-490. doi: 10.1038/s41375-023-02115-4. Epub 2024 Jan 5. Leukemia. 2024. PMID: 38177437
Inequitable Poverty Exposures: A Subspecialty Opportunity to Address Disparities.
Karvonen KA, Umaretiya PJ, Koch VB, Flamand Y, Aziz-Bose R, Ilcisin L, Valenzuela A, Cole PD, Gennarini LM, Kahn JM, Kelly KM, Tran TH, Michon B, Welch JJG, Wolfe J, Silverman LB, Rosenberg AR, Bona K. Karvonen KA, et al. Among authors: flamand y. Hosp Pediatr. 2024 Feb 1;14(2):e104-e106. doi: 10.1542/hpeds.2023-007482. Hosp Pediatr. 2024. PMID: 38239110 No abstract available.
26 results